The FTC's War On 'Pay-For-Delay' Agreements
"Pay-for-delay" agreements or "reverse payment settlements" are agreements in which a branded drug company pays its potential competitor to abandon a patent challenge and delay offering a generic version. According to...To view the full article, register now.
Already a subscriber? Click here to view full article